Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Stock news
These are the marijuana stocks with the best value, fastest growth, and most momentum for December 2021.
These are the marijuana stocks on the Nasdaq with the best value, fastest growth, and most momentum for December 2021.
If you are building a properly diversified stock portfolio, the chances are some of your picks will perform badly. Long...
Canada's main stock index rose on Tuesday, snapping its four-day losing streak as gains in energy shares on higher oil prices and OrganiGram Holdings Inc's upbeat results offset mining companies that followed gold prices lower. The Toronto Stock Exchange's S&P/TSX composite index closed up 33 points, or 0.15%, at 21,453.77. "It seems the oil price is reacting strongly to the U.S. front-running its release of barrels from the strategic reserve," said Steve Belisle, portfolio manager at Manulife...
Investors seemed to be taking a "sell the rumor, buy the news" approach with Canadian cannabis company Organigram Holdings (NASDAQ: OGI) over the past couple of weeks. Its shares declined by 25% during the two weeks leading up to its fiscal fourth-quarter earnings report that came out Tuesday morning. As of 12:51 p.m. ET, Organigram shares had pulled back somewhat, but remained up by 10.7%.
Organigram (NASDAQ:OGI) stock is heading higher today on the release of the cannabis company’s fiscal Q4 earnings report. Source: Shutterstock Let’s hash out the details from that earnings report below! Starting off the company’s earnings is net revenue of $24.9 million during the most recent quarter. That represents a 22% growth from Organigram’s Q3 2021 revenue. It’s also a 22% increase year-over-year for the company’s revenue in Q4. Organigram also notes that its market share for recreational
OrganiGram (OGI) delivered earnings and revenue surprises of -75% and 3.22%, respectively, for the quarter ended August 2021. Do the numbers hold clues to what lies ahead for the stock?
MONCTON, New Brunswick, November 23, 2021--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the "Company" or "Organigram"), a leading licensed producer of cannabis, announced its results for the fourth quarter ended August 31, 2021 ("Q4 Fiscal 2021").